Capabilities
The capabilities are divided into two parts:
FORMULATION
The professional knowledge, facility, and equipment used in pharmaceutical companies to formulate and manufacture pharmaceutical products determine the product's quality. According to this point, Rad Behin Danesh Company has created the necessary capacity for formulation in different forms. Relying on the technical knowledge of its expert scientist and advanced equipment, Rad Behin Danesh Group has the ability to research and develop and produce products in injection, inhalation, topical and oral forms.
NANOTECHNOLOGY
The astonishing progress of nanotechnology in the past decades has led to the development of a wide range of nanotechnology-based platforms for diagnosing and treating many diseases. In this regard, Rad Behin Danesh has made many efforts to use nanotechnology to improve targeted drug delivery and damage diagnosis. These efforts have led to products based on nanoemulsions, nanoparticles, and liposomes. Our team is able to produce pharmaceutical products based on nanotechnology with the help of the production of liposomes, nanoemulsions, nanolipids, nanopolymers, and nanocrystals.
These products can easily penetrate the target tissue, improve the properties of the drug or add new functionality to them. Also, identification devices, including DLS, TEM, XRD, SEM, etc., are used to approve the formation of formulations based on nanotechnology.
Here is a summary of Rad Behin Danesh's capabilities in nanotechnology:
- Design and formulation of pharmaceutical products and nutritional supplements based on nanoemulsion
- Design and formulation of pharmaceutical products and nutritional supplements based on liposomes
- Design and formulation of pharmaceutical products and nutritional supplements based on nanoparticles
- Optimizing formulations based on nanotechnology with the longest stability time
- Chromatographic methods in order to determine the amount of effective substance in nanoformulations
BIOTECHNOLOGY
In the last decade, the number of medicines developed in the field of biotechnology has increased significantly. In this regard, Rad Behin Danesh Company has seriously started its activity in this field to cover part of the country's need for biotechnological drugs. Our current projects focus on breeding in Ecola and Pichia pastoris hosts. Various chromatographic methods (such as affinity chromatography, ion exchange, HPLC, etc.) are used for step-by-step purification. In addition, one of the company's main goals is to develop biological drugs that, after initial production in the cellular host, are improved during chemical changes in terms of various characteristics such as effectiveness, half-life, release rate, etc.
Radbehin Danesh's capabilities in biotechnology include the following:
- Designing gene constructs for prokaryotic and eukaryotic hosts
- Chemical transformation and electroporation
- Recombinant protein expression in prokaryotic and eukaryotic hosts
- Optimizing the expression level in prokaryotic and eukaryotic hosts
- Chromatographic methods for the purification of recombinant proteins
- Methods of determining the properties of biological compounds
SYNTHESIS
By creating the necessary infrastructure and relying on expert scientists' knowledge and experience in synthesizing raw pharmaceutical materials (API), Rad Behin Danesh develops high-tech products. Also, it is working to meet the country's pharmaceutical requirements by establishing constructive cooperation with well-known companies in this field.
Summary of capabilities of Rad Behin Danesh in the synthesis of pharmaceutical raw materials:
- Synthesis of primary and secondary medicinal materials with high efficiency and purity
- Synthesis of effective medicinal substances using biocatalysts
- Design and synthesis of drugs based on bioconjugation
